Association of kidney function with SGLT2 inhibitor discontinuation among United States Veterans.
美國退伍軍人中腎功能與 SGLT2 抑制劑停用的關聯。
Clin J Am Soc Nephrol 2024-08-21
Predictors and Outcomes of SGLT2 Inhibitor Discontinuation in a Real-World Population after Hospitalization for Heart Failure.
SGLT2 抑制劑在心臟衰竭住院後真實世界人群中停用的預測因子和結果。
Biomedicines 2023-03-31
Short-term outcomes after sodium-glucose cotransporter-2 inhibitor initiation in a cohort of heart failure patients.
心衰患者中鈉葡萄糖共轉運輸蛋白-2抑制劑啟動後的短期結果。
ESC Heart Fail 2023-10-14
Post-initiation predictors of discontinuation of the sodium-glucose cotransporter-2 inhibitors: A comparative cohort study from the United Kingdom.
英國的一項比較性同期研究:鈉葡萄糖共同轉運蛋白-2抑製劑的停用後預測因子。
Diabetes Obes Metab 2023-11-15
Kidney Outcomes with Sodium-Glucose Cotransporter-2 Inhibitor Initiation after AKI among Veterans with Diabetic Kidney Disease.
糖尿病腎病患者 AKI 後開始使用鈉葡萄糖共轉運輸蛋白-2 抑製劑的腎臟結果。
Kidney360 2024-04-10
Real-world effectiveness of sodium-glucose cotransporter-2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria.
非糖尿病患者中鈉葡萄糖共同轉運蛋白2抑制劑對慢性腎臟病進展的實際效果:有無白蛋白尿的患者。
Diabetes Obes Metab 2024-04-29
Sodium-glucose co-transporter-2 inhibitors use in patients with reduced kidney function hospitalized for fluid overload and heart failure: an observational study.
在因液體過載和心臟衰竭住院的腎功能減退患者中使用鈉-葡萄糖共轉運蛋白-2抑制劑:一項觀察性研究。
Cardiorenal Med 2024-07-21
Impact of age on eGFR dynamics following sodium-glucose cotransporter 2 inhibitor therapy: A real-world study.
年齡對於接受鈉-葡萄糖共轉運蛋白 2 抑制劑治療後 eGFR 動態的影響:一項實際世界研究。
Diabetes Res Clin Pract 2024-07-31
Retrospective analysis of the effect of SGLT-2 inhibitors on renal function in patients with type 2 diabetes in the real world.
SGLT-2 抑制劑對於真實世界中 2 型糖尿病患者腎功能影響的回顧性分析。
Front Pharmacol 2024-08-20
Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD.
慢性腎病患者中鈉-葡萄糖共轉運蛋白-2抑制劑和類胰高血糖素肽-1受體激動劑的停用。
J Am Soc Nephrol 2024-08-26
Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease.
鈉-葡萄糖共轉運蛋白 2 抑制劑對糖尿病及晚期慢性腎病患者心血管和腎臟結果的影響。
Diabetologia 2024-08-29